title: SMFM Statement: clarification of recommendations regarding cell-free DNA aneuploidy screening.
abstract: The purpose of this statement is to clarify that the Society for Maternal-Fetal Medicine (SMFM) does not recommend that cell-free DNA aneuploidy screening be offered to all pregnant women, nor does it suggest a requirement for insurance coverage for cell-free DNA screening in women at low risk of aneuploidy. However, SMFM believes, due to the ethics of patient autonomy, that the option should be available to women who request additional testing beyond what is currently recommended by professional societies.
mesh_terms: D000782:Aneuploidy; D002474:Cell-Free System; D004247:DNA / Q000097:blood*; D004282:Documentation; D005260:Female; D005820:Genetic Testing; D006801:Humans; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D011296:Prenatal Diagnosis / Q000379:methods*
chemical_list: D004247:DNA
keywords: cell-free DNA aneuploidy screening; diagnostic testing; genetic testing; prenatal aneuploidy screening